Qilu Pharmaceutical Co., Ltd.
- 194 clinical trials, 101 active
- 5 FDA-registered drug sites
Life science companies
Explore 18,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Wacker Biotech
On BioBridgeX
- 2 FDA-registered drug sites
Ancora Heart, Inc.
- Raised $80 million (2021)
- 9 clinical trials, 2 active
Angiocrine Bioscience, Inc.
- Raised $2.1 million (2025)
- 4 clinical trials, 1 active
- Founded 2012
Aveta Biomics, Inc.
- Raised $4.5 million (2025)
- 4 clinical trials, 3 active
- Founded 2013
Axonics, Inc.
- 9 clinical trials, 5 active
BiomX Inc.
- Raised $3.3 million (2026)
- 4 clinical trials, 1 active
- Founded 2017
Claris Biotherapeutics, Inc.
- Raised $2.3 million (2025)
- 4 clinical trials, 3 active
- Founded 2018
Corin Limited
- 19 clinical trials, 5 active
- Founded 1985
Excelsior Holdings, L.P.
- Raised $48 million (2018)
- 4 clinical trials, 2 active
- Founded 2018
Eyevensys S.A.S.
- Raised $10 million (2021)
- 4 clinical trials, 1 active
- Founded 2018
Flame Biosciences, Inc.
- Raised $100 million (2020)
- 4 clinical trials
- Founded 2017
Gene Solutions LLC
- Raised $5.3 million (2024)
- 9 clinical trials, 8 active
Global Blood Therapeutics, Inc.
- 9 clinical trials
GPN Vaccines, Inc.
- Raised $3.5 million (2026)
- 4 clinical trials, 1 active
- Founded 2025
Intezyne Technologies, Inc.
- Raised $480,000 (2016)
- 1 clinical trial
- Research grants: $1.4 million
Invirsa, Inc.
- Raised $2.9 million (2025)
- 4 clinical trials
- Founded 2016
Lapix Therapeutics Inc.
- Raised $5.5 million (2025)
- 4 clinical trials, 2 active
- Founded 2019
Navitor Pharmaceuticals, Inc.
- Raised $20 million (2020)
- 4 clinical trials
- Founded 2010
Neurelis, Inc.
- Raised $115 million (2021)
- 4 clinical trials
- Founded 2007
Showing 3,740 of 18,266 companies
Load morePublished company profiles only; counts update daily. Data licences